INTRODUCTION
Proteins that bind DNA play a critical role in regulating gene structure, replication and expression in all organisms. Biochemical and structural analyses of proteins that bind specific DNA sequences have begun to provide insight into the molecular basis of both DNA binding and sequence-specific DNA recognition (1) (2) (3) . These analyses have identified protein folds for DNA binding, together with a few general rules for the protein-mediated recognition of specific DNA bases (1, 4, 5) . This work has also begun to suggest ways to modify the recognition specificity of existing, sequence-specific DNA-binding proteins. Two classes of site-specific DNA-binding proteins that have been the focus for efforts to engineer new DNA recognition specificities are the Type II restriction endonucleases (6) , and sequence-specific transcription factors (1, 7) .
The homing endonucleases, a group of highly sequencespecific DNA-binding proteins, are also being investigated for recognition specificity engineering. Four different families of homing endonuclease proteins have been identified on the basis of protein sequence comparisons, and one or more families have been identified in all Kingdoms of life (8, 9) . The physiologic role of homing endonucleases is to target the lateral transfer of parasitic DNA elements known as mobile introns by making a highly sequence-specific DNA double-strand break in an intron-less recipient allele (8, 9) .
The high site specificity of many homing endonucleases reflects a combination of long (15-40 bp) DNA target or 'homing' sites, together with a high degree of sequence specificity at most target site base-pair positions. A second intrinsic property of many homing endonucleases is tight coupling of site recognition to catalysis (10) . This is a particularly attractive feature of homing endonucleases, in contrast to other potential genome engineering reagents such as zinc finger nucleases (11) . High site specificity and tight coupling of site binding to catalysis may reflect the evolutionary history of many homing endonucleases: these two properties in concert permit the continued lateral transfer-and thus the persistence-of endonuclease-encoding mobile introns to related target sites, while minimizing spurious chromosome cleavage events (12, 13) .
Our aim was to determine whether structure-guided protein engineering could be used to alter the DNA recognition specificity of the eukaryotic homing endonuclease I-PpoI, a member of the His-Cys box family of homing endonucleases. I-PpoI was originally identified as an open reading frame in a self-splicing mobile intron found in extrachromosomal copies of the 28S rRNA genes of Physarum polycephalum, a Plasmodial myxomycete slime mold (14) . It is the best characterized member of the His-Cys box family of homing endonucleases, one family in the aab-Me or His-Me endonuclease superfamily (15, 16) , and has not thus far been a focus for structureguided design.
The active form of I-PpoI is a 36 kDa homodimer that cleaves a 15-bp semi-palindromic DNA target site in the 28S Physarum rDNA locus, and in the corresponding large subunit rRNA genes of all eukaryotes [(17-19) ; Figure 1 ]. Rare target sites may also exist outside the rDNA repeats (20) . We had previously determined highresolution apo-and co-crystal structures of native and mutant forms of I-PpoI that allowed us to identify the molecular basis for high affinity site binding and cleavage (21, 22) . We had also identified amino acid changes that interfere with I-PpoI catalysis or site binding, together with DNA base-pair changes that disrupted target site cleavage by native I-PpoI protein (23) (24) (25) (26) . These data were used to construct a yeast one-hybrid (Y1H) screening assay to identify I-PpoI protein variants able to bind a specific mutant target site in vivo. Biochemical characterization together with computational modeling were used to gain insight into the molecular basis for mutant site recognition and cleavage by variant I-PpoI proteins.
MATERIALS AND METHODS

Plasmids and yeast strains
Yeast reporter plasmids were constructed using the YEp24 two-micron plasmid vector or the integrating plasmid vector pRS404 (27, 28) . An I-PpoI-specific YEp24-lacZ reporter was constructed by inserting I-PpoI target sites into the SalI site upstream of a cyc5 promoter and lacZ gene. Target site inserts were prepared by annealing phosphorylated oligonucleotides (PPOSITES5 and PPOSITES6; all oligonucleotide sequences are given in Supplementary Data Table 1 ), or oligonucleotides that when annealed created three oriented copies of native or mutant I-PpoI target sites (oligonucleotides PPOX3_WT and _6 #1-4). Yep24-HIS3Ppo was constructed from the resulting plasmids by replacing the lacZ gene with a PCR fragment containing the budding yeast HIS3 gene. An integrating version of Yep24-HIS3Ppo was constructed by transferring an EcoRI fragment containing a multiple-cloning site, minimal promoter and HIS3 gene into the yeast TRP1 integration vector pRS404, and then inserting three copies of the native or +6C/-6G mutant I-PpoI target site as described earlier Yeast containing an integrated copy of pRS404-HIS3Ppo were constructed by transforming MfeI-cleaved linear plasmid DNA into yeast strain W1588-4C (MATa ade2-1 can1-100 his3-11, 15 leu2-3, 112trp1-1 ura3-1 RAD5), followed by selection on SD media lacking tryptophan (29, 30) . Selection for HIS3 reporter expression was performed by growth on SD medium lacking histidine, followed by a demonstration of growth suppression by 3 mM 3-aminotriazole. All reporter plasmids and strains were verified by DNA sequencing of the I-PpoI target site region.
Generation of I-PpoI protein variants
CR library. Expression plasmids for Ppo-activation domain (AD) fusion proteins were constructed by inserting I-PpoI open reading frame cassettes in-frame into the GAL4 activation domain plasmid pOAD (kindly provided by Stan Fields, University of WA, USA). The corrected map and sequence of this plasmid can be found at: depts.washington.edu/sfields/protocols/pOAD.html. After removing flanking BamHI sites, the open reading frame of catalytically inactive H98A I-PpoI was inserted into the NcoI and PstI sites of pOAD to form pOAD-Ppo. A 3 kb insert or 'dummy' fragment was inserted into the NdeIBamHI site in the I-PpoI ORF to create pOAD-Ppo+d. This 'dummy' fragment was subsequently replaced with an oligonucleotide insert encoding 25 codons of the I-PpoI ORF to restore the open reading frame and randomize I-PpoI residues N57, R61, Q63, K65 and R74. This insert was constructed by the annealing of three oligonucleotides, PPO(-)5, PPO+ NDEI and PPO NDEI SPLINT and ligation, at 500-fold molar excess, into NdeI-cut pOAD-Ppo+d. The PPO(-)5 oligonucleotide region containing randomized codons was converted to doublestranded DNA by primer extension with Klenow DNA polymerase prior to cleaving the resulting insert and plasmid with BamHI (31), ligation and electroporation into E. coli TB1 cells. The number of independent transformants was determined by plating a small portion of the pooled transformation, and the library was amplified by growth overnight in 1 l of L-broth followed by plasmid DNA isolation [(32); Qiagen MegaPrep].
RD1 and RD2 libraries. The RD1 and RD2 libraries were constructed by replacing the region encompassing I-PpoI residues 55-76 with an insert generated by PCR-mediated assembly of degenerate oligonucleotides. Five oligonucleotides (the 4 +6G_B oligonucleotides and PPOOADN were used to assemble the N-terminal portion of the I-PpoI H98A ORF. Two +6G_E oligonucleotides and PPOOADC (RD1) or PPOOADCdeg (RD2) were used to assemble the C-terminal portion of the I-PpoI ORF. PPOADCdeg included a 9 bp randomized 'molecular bar tag' sequence to allow different starting plasmids to be distinguished. Both PCR assembly products were gel purified by polyacrylamide gel electrophoresis (PAGE). The N-terminal assembly product was extended in a second PCR reaction using a pool of 27 (RD1) or 18 (RD2) +6_M oligonucleotides together with PPOOADN. The resulting product was gel-purified and amplified with recombination cloning primers AD70F and AD70R (kindly provided by Stan Fields, University of WA; http:// depts.washington.edu/sfields/protocols/protocols.html) to generate a full-length I-PpoI open reading frame insert, and then used for in vivo gap repair of PvuII + NcoIcleaved pOAD-Ppo plasmid DNA.
Ppo-AD libraries were characterized by sequencing plasmid DNA isolated from independent colonies. Seventy-four CR library plasmids were sequenced, 11 from plasmid preps and 63 from PCR products generated using PADSCREENF and PADSCREENB oligonucleotides. RD1 and RD2 were characterized by sequencing yeast colony PCR products. PCR and the sequencing were performed with PADSEQF and 882 oligonucleotide primers. The resulting forward and reverse sequences were aligned using Sequencher (www.sequencher.com).
Site-directed mutagenesis. The I-PpoI open reading frame was subcloned from Ppo-AD fusion plasmids into a pET11c derivative containing an N-terminal hexahistidine affinity purification tag prior to expression in E. coli and purification by Ni-NTA affinity chromatography (Qiagen). The pET11c-histagPpo expression vector was constructed by annealing oligonucleotides pEThistagf and pET-histagr containing the affinity tag, followed by ligation into the NdeI site of pET-Ppo (23), to generate pET11c-histagPpo. Site-directed mutagenesis using a QuikChange protocol (Stratagene) was then used to generate pET vectors expressing variants A, B, C, F, P, Q, R, S, T, Y and H98A/L116A. Variants U, V and W were made by site-directed mutagenesis of the variant C expression vector. Variants D, E, G, H, J, K, L, M and N were constructed by inserting an NcoI-BamHI fragment from RD2 Ppo-AD plasmids into the open reading frame of pET11c-histagPpo.
Library screening and b-galactosidase activity assays CR or RD library screening was performed by transforming CR or RD plasmid libraries, together with the +6C/-6G lacZ reporter plasmid Yep24-lacZPpo, into cells possessing an integrated copy of the pRS404-HIS3Ppo reporter plasmid. The resulting cells were then selected for growth on histidine-minus media followed by a visual screen for b-galactosidase activity. The number of independent co-transformants was determined by plating a small known fraction of the transformed yeast on SD-leucine-uracil plates. Library screening was performed by dense plating of transformed cells on SD-leucine-uracil-histidine plates supplemented with 3 mM 3-aminotriazole, followed by growth at 308C for 7 days. Large colonies were then picked into 1 ml 96-well deep blocks containing SD-leucine-uracil media and grown for 7 days without shaking at 308C.
A colorometric screen for b-galactosidase reporter gene induction was used to identify Ppo-AD plasmids with in vivo site-binding activity. In brief, cells were pelleted, then resuspended and permeabilized in Z-buffer using SDS and chloroform (33) . The b-galactosidase substrate ONPG was added to 0.6 mg/ml, and wells were incubated at 308C to monitor color change. Incubations were stopped between 2 and 4 h by adding Na 2 CO 3 prior to visual screening to identify positive wells by comparison against positive control (H98A Ppo-AD and native I-PpoI site lacZ reporter) or negative control (H98A Ppo-AD and mutant +6C/-6G site lacZ reporter) cells.
Ppo-AD coding plasmids were recovered from activitypositive cells by use of either a Qiagen or Sigma miniprep kit, amplified by transformation and growth in E. coli, and then transformed into yeast strain W1588-4C. We assayed at least eight transformants from each original positive colony for b-galactosidase induction by ONPG assay prior to streaking cells on SD-leucine plates supplemented with 5-fluoroorotic acid (5-FOA) to eliminate the URA3 reporter plasmid. In order to verify sitespecific b-galactosidase induction, plasmid DNAs from activity-positive cultures were retransformed as described above with a +6C/À6G or native site reporter plasmid. The DNA sequence of the Ppo-AD open reading frame was determined from the same plasmid preparation by sequencing using a PADSCREENF sequencing primer.
Quantitative b-galactosidase activity assays were performed to further characterize several I-PpoI variants by using a modification of the screening assay as described above (33) . Cells were grown overnight at 308C in SD-leucine-uracil media. Cell density was determined by measuring absorbance at 600 nm, and 2 ml of each culture was pelleted and resuspended in 0.8 ml of Z-buffer followed by the addition of 50 ml 0.1% SDS and 50 ml chloroform with vortexing for 30 s. Activity was measured by adding 160 ml of 4 mg/ml ONPG in Z-buffer followed by incubation at 308C, and stopped by adding 0.4 ml Na 2 CO 3 after the development of yellow color. Cell debris was spun out of reactions prior to measuring absorbance at 420 nm and calculating units of b-galactosidase activity. All reported values represent an average of three independent determinations.
Protein expression and purification
Variant I-PpoI proteins subcloned into pET11c-histagPpo were expressed in E. coli host strain BL21(DE3) (Novagen). Single colonies were picked into 2-3 ml of L-broth supplemented with 100 mg/ml carbenicillin and 0.2% glucose, then grown overnight at 378C. Overnight cultures (300 ml each) were then diluted into 100 ml of L-broth supplemented with carbenicillin and 1 mM zinc acetate and grown for 2-4 h at 378C. Protein production was induced by adding 1 mM IPTG. After induction for 3-5 h at 378C, cells were pelleted and stored overnight at À808C.
Protein was purified from frozen cell pellets by thawing and resuspending cells in 1 ml of lysis buffer (50 mM NaH 2 PO 4 , 300 mM NaCl and 10 mM imidazole) containing 1 mg/ml lysozyme on ice, followed by the addition of protease inhibitors (1 mM PMSF, 1 mg/ml leupeptin and 1 mg/ml pepstatin) and sonication. RNAse A (10 mg/ml) and DNAse I (5 mg/ml) were added to cell lysates followed by incubation on ice for 15 min. Cell debris was pelleted at 48C, and Ni-NTA resin (100 ml; Qiagen) was added to the cleared supernatant prior to incubation at 48C on a roller for 1-2 h. Resin was pelleted from the supernatant in a benchtop centrifuge at 48C, washed once with 1 ml of 20 mM imidazole buffer (50 mM NaH 2 PO 4 , 300 mM NaCl and 20 mM imidazole), and then washed twice with 1 ml 50 mM imidazole buffer (50 mM NaH 2 PO 4 , 300 mM NaCl and 50 mM imidazole). Protein was eluted with 3 Â 50 ml washes of 50 mM NaH 2 PO 4 , 300 mM NaCl and 250 mM imidazole. Eluates were pooled to determine protein concentration by Bradford assay prior to the addition of glycerol to 50% (v/v) and storage at À208C. Polyacrylamide gel electrophoresis of protein samples followed by Coommassie staining indicated that I-PpoI protein preparations were typically >75% pure with no other major contaminating bands.
Site-binding affinity and cleavage assays
The binding affinity (K d ) and cleavage of I-PpoI target sites were determined as previously described (26) . The substrates for binding affinity assays were formed by annealing gel-purified PPOx1 oligonucleotide pairs in which (+) strand oligonucleotides had been end-labeled with 32 P. K d values were determined from a minimum of two, or in most cases three, independent assays. Cleavage assays were performed using linearized plasmids containing either three copies of native or mutant I-PpoI target sites inserted into the SalI site of pRS404-HIS3Ppo, or single site PPOx1_Sal oligonucleotides pairs that had been annealed and inserted into pBlueScriptII KS(+) plasmid DNA (Stratagene). pRS404 plasmids were linearized with SnaBI, and pBluescriptII plasmids with XmnI, prior to performing cleavage assays.
Computational modeling of I-PpoI variants
Modeling of the I-PpoI DNA interface of native and variant proteins was done using RosettaDesign (34, 35) . In brief, changes to the substrate DNA sequence and the amino acid sequence of the protein were simulated in silico, and the DNA-protein complex was allowed to relax according to an energy function that mimics protein folding. I-PpoI variants E, G and T were modeled and visualized for inspection using the PyMOL molecular viewer (DeLano Scientific LLC).
RESULTS
Cleavage sensitivity of I-PpoI target site variants
We identified I-PpoI target sites that were cleavageresistant when challenged with native I-PpoI protein. We focused initially on 5-bp positions, AE3 to AE7, and on basepair substitutions at these sites that were known to affect cleavage efficiency on the basis of previous homing site degeneracy, biochemical or functional analyses (24, 25, 36) . These base-pair positions are in a well-ordered part of the I-PpoI DNA-protein interface ( Figure 1A ). Palindromic AE3 G>A/C>T and AE4 G>C/T>G base-pair substitutions were permissive of cleavage only at high protein concentrations (10 nM for the AE3 position; 1 mM for the AE4 position). In contrast, base-pair substitutions at positions AE5 (T>A/C>T), AE6 (A>C/T>G) and AE7 (G>A/C>T) completely inhibited cleavage at all protein concentrations tested ( Figure 1D ; data not shown). Of the six possible base-pair changes from the native +6A/À6T target site, +6A>C/À6T>G substitutions most strongly inhibited site cleavage by native I-PpoI (Figure 1C and D; data not shown). We chose this target site for re-engineering of the site recognition specificity of I-PpoI.
A yeast one-hybrid screening assay
A yeast one-hybrid (Y1H) screen was used to identify I-PpoI protein variants that bound the +6C/À6G target site in vivo to induce reporter gene expression. To establish this assay, we fused a Saccharomyces cerevisiae Gal4p transcriptional activation domain to the N-terminus of catalytically inactive H98A I-PpoI to generate Ppo-AD. The H98A substitution was incorporated to abolish the catalytic activity of I-PpoI without disrupting high affinity site binding [ Figure 2A ; (22, 23, 26) ]. A Ppo-AD negative control protein was constructed by fusing L116A I-PpoI to the Gal4p activation domain. L116A I-PpoI is catalytically inactive, and does not bind I-PpoI target site DNA (26) . Reporter activity was determined using a budding yeast HIS3 or plasmid-borne bacterial lacZ reporter genes located downstream of 1 or more I-PpoI target site and a minimal promoter ( Figure 2B ). Site binding was quantified by the induction of b-galactosidase activity, and was strongest when the lacZ reporter gene was flanked by 6 direct repeats of the native I-PpoI target site: 25-to-75-fold above the 'no site' or negative control background. The Gal4-L116A Ppo-AD negative control protein did not induce reporter expression above background on any target site or number of repeats ( Figure 2C ; data not shown). We performed all subsequent library screens using reporter genes flanked by three target sites, as these reporters could be readily constructed and gave reporter activity well above background.
Generation and screening of I-PpoI protein variant libraries
In order to generate protein variants to screen against the mutant +6C/À6G target site, we made substitutions in the I-PpoI DNA-protein interface at residues that contacted base-pair position 6 or adjacent base-pair positions. This 'contacting residue' (CR) library was designed to allow all 20 amino acid residues at positions N57, R61, Q63, K65 and R74, and had a maximum potential complexity of 3.2 Â 10 6 ( 20 5 ) protein variants. The resulting CR library was difficult to construct, and thus not large enough to encompass all predicted variants. Upon experimental verification, the CR library was found to encode 1.6 Â 105 different protein variants that each had an average of 4.7 amino acid substitutions (CR library, Table 1 ).
The CR library was screened by Y1H in two steps. We isolated yeast transformants that grew on histidineminus plates containing 3-aminotriazole (3-AT), and then determined whether the same Ppo-AD plasmids could induce in vivo b-galactosidase expression. The Ppo-AD open reading frame of active variants was then sequenced to identify amino acid substitution(s) that conferred in vivo activity. Among the 2 Â 10 6 colony transformants and 4600 His+ colonies screened, only one CR library transformant had in vivo activity on both reporter genes.
This variant (variant A, Table 2 ) had four amino acid substitutions at residue positions randomized during CR library construction.
Variant A served as a starting point for the construction of two additional, rationally designed (RD) libraries that were used to further explore determinants of I-PpoI recognition and in vivo activity on native and +6C/À6G target sites. The first RD library allowed +6C/À6G contacting residue 63 to vary among seven amino acid residues: the native Q, or D, E, K, N, R or Y. Neighboring b-strand residues A55, N57, W62, Y64, R74 and G76 were substituted with residues that differed slightly in size and/ or polarity from native residues found at these positions (RD1; Table 1 ). The predicted maximum complexity of the RD1 library was 3.5 Â 10 4 . Sequencing indicated that Table 1 ).
In vivo screening of RD1 against +6C/À6G target site reporter genes yielded 352 His+ colonies, and 15 plasmids from this pool were verified by re-transformation and quantitative lacZ activity prior to sequencing. Five active Ppo-AD plasmids had the same Ppo-AD amino acid substitutions found in variant A (Table 2) . Six different RD1 starting plasmids harbored the same Q63R and K65R substitutions ( Table 2 , variant E), as indicated by plasmid DNA sequence differences. Four other plasmids had the variant E Q63R and K65R substitutions together with 2 to 4 other substitutions at residues targeted during library construction (variants B, C, D and F; Table 2 ).
A second rationally designed library was constructed to determine whether additional residue substitutions could augment the in vivo activity of Ppo-AD proteins identified in the CR and RD1 libraries. The RD2 library design features were: (i) three positions were fixed as residues found in active variants of RD1 (63R, 64Y and 76G); (ii) residue 55 was an A, G, L or V, and residue 62 was an F or W, again as previously identified in active variants; (iii) contacting residues 57, 61, 65 and 74 were varied 
The designation and source of each I-PpoI variant protein are listed in the first two columns. Positive (H98A) and negative (L116A) control proteins are listed in the first two rows for comparison. Binding affinities for native and +6C/-6G target site DNAs, determined by gel shift assay, are given in columns 3 and 4 and are arranged in order of decreasing affinity for the native I-PpoI target site. The ability of each I-PpoI variant to cleave native or +6C/-6G target site DNA was determined after reverting the catalytically inactivating H98A substitution that was required to establish the yeast one-hybrid assay. The final columns detail amino acid substitutions at nine positions in the DNA-protein interface. A blank box indicates presence of the native residue (shown top in single letter code). Key: CR, contacting residue library; RD1, RD2, rationally designed protein variant libraries RD1 and RD2; SDM, site-directed mutagenesis. Note: This Table has been reformatted in Supplementary table 2 to show variants rank-ordered on the basis of increasing number of residue substitutions at nine positions in the DNA-protein interface. The nine I-PpoI amino acid residues targeted for substitution during library constructions are indicated in the left column, together with substitutions made at each residue in the contacting residue (CR) or two rationally designed (RD1 and RD2) protein variant libraries. Maximum complexity is the predicted complexity of the library. Library size is the experimental complexity of the library, determined from the number of independent colonies that contained inact open reading frames.
among eight amino acid residues commonly found in homing endonuclease DNA-protein interfaces (Y, E, D, R, K, Q, N, C; Table 1 , RD2) and (iv) inclusion of a 9 bp post-C-terminal 'molecular bar code' to allow different RD2 plasmid molecules to be identified and distinguished. The RD2 library had a predicted maximum complexity of 3.2 Â 10 4 . Sequencing indicated that 67% of RD2 library plasmids had intact Ppo-AD open reading frames. Thus the completed RD2 library of 1.4 Â 10 5 members was sufficiently large to include all designed RD2 variants.
Thirty-five RD2 plasmids displayed in vivo activity against +6C/-6G reporter genes. These plasmids encoded nine different Ppo-AD proteins: seven Ppo-AD variants were unique to the RD2 library (variants G, H, J, K, L, M and N), whereas two variants had been previously identified in RD1 (variants D and E; Table 2 ). Ppo-AD variants D, H, K and L were independently isolated, from 3 to 6 times each from RD2, as indicated by plasmid molecular bar code sequences. In addition to these library variants, we constructed nine I-PpoI variants (variants P to Y, Table 2 ) by site-directed mutagenesis. This was done to determine the contribution of specific amino acid residues identified in the CR, RD1 and RD2 libraries to target site binding and cleavage. We reasoned that specific residue substitutions in library isolates might promote or interfere with site binding and cleavage, and thus wanted to assay individual substitutions in defined sequence contexts. These site-directed mutants were generated, in consequence, in either the native or variant A or C I-PpoI sequence contexts.
Biochemical characterization of I-PpoI variant proteins
In order to characterize the site-binding properties of Ppo-AD variants, we expressed and purified variant proteins from E. coli and then determined their dissociation constants (K d 's) on native and on +6C/-6G target site DNAs. We also determined the ability of selected variants to induce reporter gene expression in vivo to allow a comparison of in vitro and in vivo site-binding properties (Figure 3) . The I-PpoI portion of each Ppo-AD fusion protein was subcloned into a pET11c expression vector containing an N-terminal six-histidine tag to facilitate purification. In order to assay site cleavage as well as binding by specific variant proteins, we used site-directed mutagenesis to revert the catalytically inactivating H98A substitution required to establish our Y1H assay.
Dissociation constants for variant proteins were determined by electrophoretic gel mobility shift analysis using +6C/À6G and native target site DNAs. Fourteen of 22 variants displayed a higher affinity for +6C/À6G homing site DNA than did native I-PpoI, although this sitebinding preference was modest (typically <5-fold; Table 2 ). Seven of the remaining variants displayed no site-binding preference. One variant, T, displayed high binding affinity for both the native and +6C/À6G target sites and a 175-fold higher affinity for native target site DNA (Table 2) . We also determined the binding affinity of native I-PpoI and four variant proteins on target site DNAs with base-pair substitutions at the AE6 position, the AE7 position and in one instance AE6/AE7 position substitutions. The variants had amino acid substitutions at position 63 contacting the AE6 bp; at residue 74 contacting the AE7 bp; and at residues 55, 57 and 65 in adjacent regions of the DNA-protein interface. None of these variant proteins bound any mutant target site DNA with high site affinity or specificity (Table 2, and  Supplementary Table 2) .
Seven of 22 variant I-PpoI proteins cleaved native homing site DNA in vitro. Cleavage activity was determined on linear plasmid substrates that contained a single I-PpoI target site. Both native I-PpoI and variant T bound and cleaved native target site DNA, though did not cleave +6C/-6G target site DNA in the presence of Mg 2+ or Mn 2+ ( Figure 3A ; data not shown). Other variant proteins with activity cleaved only native target site DNA (variants E, P, Q, S, U and Y; Table 2 , Figure 3A) . In order to better understand the relationship between biochemical properties and in vivo activity of variant proteins, we quantified the ability of six variants to induce a lacZ reporter gene in budding yeast. Variants A, C, E, G, J and T were chosen for analysis as they represent a range of in vitro binding affinities. Expression plasmids for each variant as a Ppo-AD fusion were transformed into yeast containing a native or +6C/-6G target site LacZ reporter gene plasmid. b-Galactosidase activity was quantified for three independent colonies grown in liquid media and assayed on the same day. Protein variants C, G and J had higher activity on +6C/-6G than on native target site reporters. This paralleled the 1.8-to-5.3-fold higher binding affinity of these variant proteins for +6C/-6G sites (Table 2 and Figure 3B) . A graphical summary of in vitro site binding and site cleavage analyses, for all variants, is shown in Figure 3 (panels C and D).
Computational modeling and analysis of I-PpoI protein variants
Structural modeling of base pair and residue substitutions in the I-PpoI DNA-protein interface was used to gain mechanistic insight into the properties of several I-PpoI variant proteins. When I-PpoI is bound to native target site DNA, Q63 makes an energetically favorable, glutamine:adenine contact with two hydrogen bonds to adenine 6. R74 makes a canonical contact with guanine 7. K65 makes an H-bond contact to guanine 9, whereas R61 makes a series of backbone contacts between base pairs 3 and 4 ( Figure 1A) . Modeling indicates the +6C/-6G base-pair substitution inhibits site binding and cleavage by disrupting the glutamine:adenine 6 contact, and by forcing the Q63 residue to rotate 1358 into and in part disrupt the adjacent R74:guanine 7 bp contact ( Figure 4A and B) .
Several residue substitutions found in variant G could in part restore mutant +6C/-6G target site binding. These were Q63R at the +6C/-6G base-pair-contacting position (present in 17 variants) K65R (present in 17 variants) and R61K (present in 4 variants; Table 2 and Figure 4 , compare panels B and C). Modeling indicates that Q63R substitutions can in part restore mutant site-binding affinity by making a new contact at base-pair position 5, and by restoring an R74:guanine 7 canonical base-pair contact ( Figure 4C) . Modeling also provides an explanation for why selected variants with Q63R substitutions, e.g. variant E, show preferential binding of the mutant +6C/À6G target site: when R63 packs in the native DNA interface, it leaves a small cavity adjacent to the native AE6 A/T base pairs. This cavity is partially filled by the cytosine in the +6C/-6G substrate (Figures 1A and  4B ; data not shown). These results indicate that the native contacting residue, Q63, acts as a gatekeeper at the AE6 A:T base pair by controlling contacts at this and adjacent base-pair positions.
Variant T, which contains a K65R substitution, showed a marked increase in binding affinity for both native and +6C/-6C target sites. Modeling of this substitution revealed that K65 forms a single H-bond to the guanine base at base pair 9, whereas K65R substitution make two H-bonds to base pairs at positions 8 and 9 (compare Figure 4 panels B and C). These contacts are energetically more favorable than the single contact made by the native K65 residue (À1.22 units for R65 versus À1.09 units for K65; RosettaDesign analyses not shown). Neither K nor R65 residues contact target site position 6, and thus do not discriminate between native or mutant +6C/-6G target site DNAs.
R61K substitutions decrease the DNA-binding affinity of I-PpoI, while increasing target site selectivity to favor the binding of mutant, +6C/-6G target site DNA (compare, e.g. variants E and G, Table 2 ). Modeling indicates that the R61K substitution modifies backbone contacts in the native interface between base pair positions 3 and 4 ( Figure 4 , compare panels B and C). These backbone positions are immediately adjacent to the scissile phosphate, and form part of the most deformed region of the I-PpoI:DNA substrate complex (21) . The selectivity of K61 variants for mutant target site DNA is likely explained by sequence-dependent conformation changes in the DNA-protein interface, as no new contacts are established with mutant target site DNA.
DISCUSSION
We used a yeast one-hybrid (Y1H) assay to isolate and characterize variants of the I-PpoI homing endonuclease with altered DNA target recognition specificity. Variants were isolated using a mutant binding site target with symmetrical AE6 bp position substitutions that abolished site binding and cleavage by native I-PpoI. We reasoned that amino acid substitutions in the DNA-protein interface adjacent to this target site position, at contacting residue 63 alone or in conjunction with other substitutions, might restore high site-binding affinity and Figure 1A ). specificity in vivo. This strategy resembles Y1H screens that have been used to identify and characterize sitespecific DNA-binding proteins from yeast and other organisms. One similar precedent reported for homing endonucleases was the use of a bacterial two-hybrid screen to explore the recognition specificity of the LAGLIDADG homing endonuclease PI-SceI (37) .
The variant I-PpoI proteins we generated contained from 1 to 8 amino acid substitutions in the DNA-protein interface (Tables 1 and 2 ). Most variants had low sitebinding affinities (100-1000 nM K d 's), and a modest (2-to-10-fold) preference to bind native or mutant target site DNA. One exception, variant T with only a K65R substitution, had high binding affinities for native and mutant target site DNAs that included a clear (<175-fold) preference for native site binding. Cleavage competence was assayed by reverting the catalytically inactivating H98A substitution required to establish the Y1H screen, and then assaying proteins for the ability to cleave native or mutant target site DNAs. We found little correlation among site binding, discrimination and cleavage properties of individual variant proteins (Table 2 and Figure 3 , panels C and D). One likely explanation for this is that IPpoI must bind and bend substrate DNA in order to generate a productive substrate complex (21, 22, 26) . Our hypothesis is that active variants (e.g. variants U, S or P, Figure 3A and Table 2 ) retain the ability to both bind and bend site DNA to permit cleavage.
Structure-based molecular modeling of I-PpoI variant proteins on both native and mutant target site DNAs was used to gain insight into the contribution of specific residue substitutions to the biochemical behavior of variant proteins. Modeling revealed that Q63R substitutions fail to confer AE6 mutant target site specificity by virtue of loss of a canonical glutamine:adenine contact at position 6, together with partial disruption of a canonical arginine:guanine contact at the adjacent base pair position 7. Q63R variants were nonetheless able to discriminate in favor of mutant +6C/-6G target sites by packing more favorably with mutant 6C than with the native 6A target site base, while making a high quality contact at the adjacent position 5 base pair (Figure 4 ). K65R substitutions, in contrast, increase affinity for native and AE6 mutant target sites by making an additional H-bond to bridge base pair positions 8 and 9 [ Figures 1 and 4 (panels B and C)].
R61K substitutions, in contrast, appear to alter site binding by modifying DNA backbone contacts immediately adjacent to the scissile phosphate located between base pairs 2 and 3 [(21); Figure 4 ]. This type of indirect readout may be strongly influenced by local, sequencedependent DNA conformation (38, 39) . These sequencedependent effects may be further amplified by DNA substrate deformation in this region of the I-PpoI substrate complex, and thus interfere with correct positioning of the scissile phosphate (Figures 1 and 4) (21,26) .
The Y1H screening assay we used employed the canonical two-hybrid reporters HIS3 and lacZ that, respectively, confer a growth advantage or have readily detectable activity at low expression levels. The sensitivity of these reporters, in retrospect, permitted the identification of I-PpoI variants with modest in vivo activity and site-binding affinity (Table 2 and Figure 3) . One explanation for the failure to recover I-PpoI variants with high affinity and specificity for +6C/-6G mutant target site DNA is that they were not present in our starting libraries. This may be the case for the initial randomized contacting residue (CR) library, which was too large to be exhaustively screened. The smaller rationally designed libraries (RD1 and RD2), in contrast, were exhaustively screened but may have been too small to encode a high affinity binding variant.
The experimental and computational analyses described above indicate one productive approach to alter the DNA recognition specificity of I-PpoI and other homing endonuclease proteins. Computational DNA-protein interface design can be used to predict different residue substitutions that may confer high binding affinity and specificity for a mutant target site DNA. The resulting protein variants can then be rank-ordered on the basis of predicted DNA-binding energies, and further evaluated for structural quality by molecular modeling. This general approach has already been shown to work for single basepair positions in I-MsoI, a member of the LAGLIDADG homing endonuclease family (40) , and should be applicable to His-Cys box proteins such as I-PpoI. A prerequisite for this engineering approach is a high resolution co-crystal structure.
In addition to protein computational design, it should also be possible to improve the experimental selection or screening assays to identify variant proteins with high site-binding affinity and specificity. For example, the Y1H assay could be adapted to use reporter genes or selections that would require comparatively high levels of expression to identify active variants. Alternatively, a combination of positive and negative selection could be used to recover variants with high site-binding affinity and specificity (41) .
Homing endonucleases remain the most attractive starting point for the generation of new, highly sequence-specific proteins for biology and medicine. They encode a wide range of different DNA recognition specificities, and display high site-binding specificity that is tightly linked to DNA cleavage. Homing endonucleases including I-PpoI have already been successfully expressed in human cells. They cleave their target sites with high site specificity (19, (42) (43) (44) , and thus are being used to promote site-specific recombination (45) and high resolution DNA double-strand break repair analyses (20) . The precedents outlined above indicate that it should be possible in the near future to generate many highly sequence-specific homing endonuclease variants useful for genome engineering, disease therapy or disease prevention. design, library construction and graphics support. Stan Fields and his laboratory provided generous help in establishing the yeast one-hybrid assay, and Barry L. Stoddard for I-PpoI structure determinations, initial structural modeling and continuous discussion. U.S. National Institutes of Health RO1 and T32 funding (RO1 CA88942 to R.J.M., Jr; T32 GM07735 to J.L.E. T32 GM07270 to J.E. and T32 GM007266 and T32 CA077116 to U. U.). U. U. is also the recipient of a Poncin Fund Award. Funding to pay the Open Access publication charges for this article was provided by the U.S. National Institutes of Health.
